Visirna Therapeutics HK Limited
Quick facts
Phase 3 pipeline
- Placebon · Psychiatry
Placebon is a small molecule that targets the serotonin receptor. - VSA003
VSA003 is an investigational therapeutic targeting viral or cellular mechanisms relevant to its indication in phase 3 development.
Phase 2 pipeline
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
- Visirna Therapeutics HK Limited portfolio CI brief
- Visirna Therapeutics HK Limited pipeline updates RSS
Frequently asked questions about Visirna Therapeutics HK Limited
What is Visirna Therapeutics HK Limited's pipeline?
Visirna Therapeutics HK Limited has 2 drugs in Phase 3, 1 in Phase 2, 1 in Phase 1. Late-stage candidates include Placebon, VSA003.
Related
- Sector hub: All tracked pharma companies